{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T21:45:33Z","timestamp":1794174333850,"version":"4.8.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by persistent inflammation of the colonic mucosa. This condition can significantly affect the quality of life of those affected. While UC is common, its underlying mechanisms are not yet fully understood, highlighting the need for a comprehensive proteomic analysis of intestinal tissues to identify potential biological changes associated with the disease. This study aimed to investigate the proteomic differences in the intestinal tissues of patients with UC and healthy individuals using high-throughput liquid chromatography\u2013tandem mass spectrometry (LC\u2013MS\/MS) and bioinformatics methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study employed a comprehensive proteomic analysis using LC\u2013MS\/MS to identify protein expression differences in intestinal tissues from five patients with UC versus five healthy controls. Subsequent bioinformatics analyses, including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses, elucidated altered biological processes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 194 upregulated and 323 downregulated proteins in the tissues of patients with UC, indicating a significant difference in protein expression. GO analysis revealed that the upregulated proteins were mainly involved in immune responses and metabolic processes, while the downregulated proteins were associated with organic and cellular metabolism. Additionally, KEGG pathway analysis showed that upregulated proteins were enriched in pathways related to ribosomes and phagosomes, whereas downregulated proteins were primarily linked to oxidative phosphorylation, thermogenesis, and the citric acid cycle, pointing to substantial changes in cellular energy metabolism. Protein\u2013protein interaction (PPI) network analysis identified several key nodes, particularly those connected to ribosomal and phagocytic functions, which may play significant roles in the pathophysiology of UC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study offers new insights into the biological mechanisms underlying UC and lays the foundation for future therapeutic strategies targeting these proteomic changes. Further experimental validation and clinical investigations are necessary to uncover additional mechanisms of UC and to facilitate the development of effective treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1537168","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T10:57:28Z","timestamp":1749812248000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Comprehensive proteomic profiling of intestinal tissues in patients with ulcerative colitis"],"prefix":"10.3389","volume":"12","author":[{"given":"Huiling","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"A288","DOI":"10.1016\/j.autrev.2009.11.019","article-title":"The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis","volume":"9","author":"Tobon","year":"2010","journal-title":"Autoimmun Rev"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.tips.2024.08.003","article-title":"Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments","volume":"45","author":"Wangchuk","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jama.2023.15389","article-title":"Ulcerative colitis in adults: a review","volume":"330","author":"Gros","year":"2023","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/s1470-2045(20)30156-x","article-title":"Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study","volume":"21","author":"Lee","year":"2020","journal-title":"Lancet Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3238\/arztebl.2020.0564","article-title":"Ulcerative colitis-diagnostic and therapeutic algorithms","volume":"117","author":"Kucharzik","year":"2020","journal-title":"Dtsch Arztebl Int"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev-med-052919-120048","article-title":"New therapeutics for ulcerative colitis","volume":"72","author":"Hirten","year":"2021","journal-title":"Annu Rev Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/35015709","article-title":"Proteomics to study genes and genomes","volume":"405","author":"Pandey","year":"2000","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/978-1-4020-5943-8_14","article-title":"Systems nanobiology: from quantitative single molecule biophysics to microfluidic-based single cell analysis","volume":"43","author":"Martini","year":"2007","journal-title":"Subcell Biochem"},{"key":"ref10","first-page":"1919","article-title":"FRET-based genetically-encoded sensors for quantitative monitoring of metabolites","volume-title":"Biotechnol Lett","author":"Mohsin","year":"2015"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"103017","DOI":"10.1016\/j.autrev.2021.103017","article-title":"The influence of cytokines on the complex pathology of ulcerative colitis","volume":"21","author":"Nakase","year":"2022","journal-title":"Autoimmun Rev"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejphar.2019.02.021","article-title":"iTRAQ-based pharmacoproteomics reveals potential targets of berberine, a promising therapy for ulcerative colitis","volume":"850","author":"Li","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.ijbiomac.2021.03.083","article-title":"Tremella fuciformis polysaccharides ameliorated ulcerative colitis via inhibiting inflammation and enhancing intestinal epithelial barrier function","volume":"180","author":"Xiao","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5603\/fhc.2011.0017","article-title":"Assessment of the influence of the inflammatory process on the activation of blood platelets and morphological parameters in patients with ulcerative colitis (colitis ulcerosa)","volume":"49","author":"Polinska","year":"2011","journal-title":"Folia Histochem Cytobiol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12014-019-9224-6","article-title":"Ulcerative colitis: functional analysis of the in-depth proteome","volume":"16","author":"Schniers","year":"2019","journal-title":"Clin Proteomics"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/17474124.2019.1574569","article-title":"Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis","volume":"13","author":"Greuter","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"115280","DOI":"10.18632\/oncotarget.23323","article-title":"Role of DDX3 in the pathogenesis of inflammatory bowel disease","volume":"8","author":"Tantravedi","year":"2017","journal-title":"Oncotarget"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1093\/ibd\/izz335","article-title":"Temporal gut microbial changes predict recurrent Clostridiodes difficile infection in patients with and without ulcerative colitis","volume":"26","author":"Lee","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainres.2017.01.025","article-title":"Chronic fluoxetine treatment directs energy metabolism towards the citric acid cycle and oxidative phosphorylation in rat hippocampal nonsynaptic mitochondria","volume":"1659","author":"Filipovic","year":"2017","journal-title":"Brain Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.3892\/etm.2019.7253","article-title":"Changes in expression of p53 and inflammatory factors in patients with ulcerative colitis","volume":"17","author":"Su","year":"2019","journal-title":"Exp Ther Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bbi.2024.11.032","article-title":"Upregulation of olfactory receptors and neuronal-associated genes highlights complex immune and neuronal dysregulation in long COVID patients","volume":"124","author":"Shahbaz","year":"2025","journal-title":"Brain Behav Immun"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev-immunol-081619-104850","article-title":"Krebs cycle reborn in macrophage Immunometabolism","volume":"38","author":"Ryan","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","article-title":"Physiological roles of mitochondrial reactive oxygen species","volume":"48","author":"Sena","year":"2012","journal-title":"Mol Cell"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-physiol-020518-114455","article-title":"Branched chain amino acids","volume":"81","author":"Neinast","year":"2019","journal-title":"Annu Rev Physiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"R285","DOI":"10.1152\/ajpregu.00652.2010","article-title":"Implications of nonshivering thermogenesis for energy balance regulation in humans","volume":"301","author":"van Marken","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12079-022-00695-x","article-title":"Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: focus on the available therapeutic approaches and gut microbiome","volume":"17","author":"Shahini","year":"2023","journal-title":"J Cell Commun Signal"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1021\/pr900549a","article-title":"Reduced expression of Lamin a\/C results in modified cell signaling and metabolism coupled with changes in expression of structural proteins","volume":"8","author":"Chen","year":"2009","journal-title":"J Proteome Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/metabo14040194","article-title":"Colonic dysregulation of major metabolic pathways in experimental ulcerative colitis","volume":"14","author":"Noh","year":"2024","journal-title":"Meta"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1874065","DOI":"10.1155\/2020\/1874065","article-title":"Effect of Huangqin Tang on urine metabolic profile in rats with ulcerative colitis based on UPLC-Q-Exactive Orbitrap MS","volume":"2020","author":"Wang","year":"2020","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1537168\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T10:57:29Z","timestamp":1749812249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1537168\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":30,"alternative-id":["10.3389\/fmed.2025.1537168"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1537168","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"article-number":"1537168"}}